Ng AT, Tower RL, Drolet BA. Targeted treatment of vascular anomalies. Int J Womens Dermatol. 2021 Dec;7(5Part A):636-639 PMID: 35024417 PMCID: PMC8721128 01/14/2022
Ng AT, Tower RL, Drolet BA. Targeted treatment of vascular anomalies International Journal of Women\'s Dermatology. December 2021;7(5):636-639 SCOPUS ID: 2-s2.0-85120812131 12/01/2021
Zhang A, Duchatelet S, Lakdawala N, Tower RL, Diamond C, Marathe K, Hill I, Richard G, Diab Y, Kirkorian AY, Watanabe F, Siegel DH, Hovnanian A. Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome. JAMA Dermatol. 2020 Feb 01;156(2):196-200 PMID: 31895414 PMCID: PMC6990762 SCOPUS ID: 2-s2.0-85077707138 01/03/2020
Siegel DH, Tower R, Drolet BA. What do mosaic RASopathies tell us about carcinogenesis? Br J Dermatol. 2018 Nov;179(5):1031-1032 PMID: 30387507 SCOPUS ID: 2-s2.0-85055889219 11/06/2018
Tower RL. Kaposiform haemangioendothelioma: new insights and old problems. Br J Dermatol. 2018 Aug;179(2):253-254 PMID: 30141555 SCOPUS ID: 2-s2.0-85052202804 08/25/2018
Mink R, Schwartz A, Carraccio C, High P, Dammann C, McGann KA, Kesselheim J, Herman B, Steering Committee of the Subspecialty Pediatrics Investigator Network. Creating the Subspecialty Pediatrics Investigator Network. J Pediatr. 2018 Jan;192:3-4.e2 PMID: 29246355 SCOPUS ID: 2-s2.0-85041093814 12/17/2017
Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL 2nd, Burke MJ. Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. J Pediatr Hematol Oncol. 2017 Jul;39(5):e254-e258 PMID: 28452856 PMCID: PMC5591641 SCOPUS ID: 2-s2.0-85021364265 04/30/2017
Lapadat R, Tower RL 2nd, Tam W, Orazi A, Gheorghe G. Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant. Pediatr Blood Cancer. 2016 May;63(5):935-7 PMID: 26773805 SCOPUS ID: 2-s2.0-84980042088 01/17/2016
Tower RL, Jones TL, Camitta BM, Asselin BL, Bell BA, Chauvenet A, Devidas M, Halperin EC, Pullen J, Shuster JJ, Winick N, Kurtzberg J. Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children\'s Oncology Group. J Pediatr Hematol Oncol. 2014 Jul;36(5):353-61 PMID: 24608079 PMCID: PMC4120865 SCOPUS ID: 2-s2.0-84903760629 03/13/2014
Thakar MS, Talano JAM, Tower RL, Kelly ME, Burke MJ. Indications for transplantation in childhood acute leukemia and the impact of minimal residual disease on relapse: A review Clinical Practice. January 2014;11(1):79-90 SCOPUS ID: 2-s2.0-84896522397 01/01/2014